I don't believe Jason would say that. It would rui
Post# of 30028
Posted On: 11/10/2014 5:09:42 PM
I don't believe Jason would say that. It would ruin his credibility. He has a price target for AMBS at .20 cents by year end. He has said LymPro's revenue potential under CLIA is "several hundred million."
One million for 2015 would be a total failure of Lympro. He is not saying that. He is saying now is a good time to buy ;AMBS. Something doesn't add up.
One million for 2015 would be a total failure of Lympro. He is not saying that. He is saying now is a good time to buy ;AMBS. Something doesn't add up.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼